Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ian Wrench is active.

Publication


Featured researches published by Ian Wrench.


Journal of Anxiety Disorders | 2011

How do memory processes relate to the development of posttraumatic stress symptoms following childbirth

Emma Briddon; Pauline Slade; Claire L. Isaac; Ian Wrench

Some women develop posttraumatic stress symptoms (PTSS) following childbirth but little is known about memory processes following childbirth. Models of traumatic memory debate the role of memory disorganization. This study investigates whether there is an association between memory disorganization and PTSS in new mothers. One hundred and twenty-two women were recruited within 72h of giving birth, completing measures of cognitive and emotional experience, and analgesia, and a narrative account of the birth. 68 of these women responded to a six-week follow-up and completed measures of memory disorganization and PTSS. There was a relationship between memory disorganization and PTSS at follow-up, but not at recruitment. The organization of the immediate narrative may not distinguish between those who later do or do not develop symptoms. Emotional evaluation may be the key factor in facilitating or inhibiting the memory construction process, linking memory to subsequent disorganization and hence to symptoms.


BMC Pregnancy and Childbirth | 2017

Enhanced recovery after elective caesarean: a rapid review of clinical protocols, and an umbrella review of systematic reviews

Ellena Corso; Daniel Hind; Daniel Beever; Gordon Fuller; Matthew Wilson; Ian Wrench; Duncan Chambers

BackgroundThe rate of elective Caesarean Section (CS) is rising in many countries. Many obstetric units in the UK have either introduced or are planning to introduce enhanced recovery (ER) as a means of reducing length of stay for planned CS. However, to date there has been very little evidence produced regarding the necessary components of ER for the obstetric population. We conducted a rapid review of the composition of published ER pathways for elective CS and undertook an umbrella review of systematic reviews evaluating ER components and pathways in any surgical setting.MethodsPathways were identified using MEDLINE, EMBASE and the National Guideline Clearing House, appraised using the Appraisal of Guidelines for Research and Evaluation (AGREE II) tool and their components tabulated. Systematic reviews were identified using the Cochrane Library and Database of Abstracts of Reviews of Effects (DARE) and appraised using The Grading of Recommendations Assessment, Development and Evaluation (GRADE). Two reviewers aggregated summaries of findings for Length of Stay (LoS).ResultsFive clinical protocols were identified, involving a total of 25 clinical components; 3/25 components were common to all five pathways (early oral intake, mobilization and removal of urinary catheter). AGREE II scores were generally low. Systematic reviews of single components found that minimally invasive Joel-Cohen surgical technique, early catheter removal and post-operative antibiotic prophylaxis reduced LoS after CS most significantly by around half to 1 and a half days. Ten meta-analyses of multi-component Enhanced Recovery after Surgery (ERAS) packages demonstrated reductions in LoS of between 1 and 4 days. The quality of evidence was mostly low or moderate.ConclusionsFurther research is needed to develop, using formal methods, and evaluate pathways for enhanced recovery in elective CS. Appropriate quality improvement packages are needed to optimise their implementation.


International Journal of Obstetric Anesthesia | 2016

Enhanced recovery pathway for elective caesarean section

Elizabeth Coates; Gordon Fuller; Daniel Hind; Ian Wrench; Matthew Wilson; T. Stephens

Caesarean section (CS) is one of the most common surgical procedures performed by the UK National Health Service. In 2013–14, over 73000 (44%) were planned or ‘elective’ operations. Caesarean section is associated with longer hospital stays than spontaneous birth, despite recommendations by the UK National Institute for Health and Care Excellence (NICE) that women can go home 24 h after surgery if recovering well. Women have expressed a strong desire for earlier discharge after elective CS provided their care needs are met. The proportion of women leaving hospital the day after elective CS continues to rise in the UK, suggesting that enhanced recovery (ER) principles are being practised, albeit inconsistently. We aimed to identify current practice through an online survey of UK maternity units, and to reach consensus on an ER clinical pathway with inbuilt quality improvement (QI) components for elective CS. An expert consensus workshop using the Nominal Group Technique (NGT) and a round-table discussion was held in March 2015. Thirty-six academic maternity units which were participating in national randomised controlled trials (ISRCTN29654603 or ISRCTN66118656) were invited by e-mail to take part in the online survey. Lead obstetric anaesthetists completed a web-based survey application (Survey Monkey, Palo Alto, CA, USA). Completion of the questionnaire was taken as implied consent to participate. The survey was completed by 30 maternity units (83%). Fifty percent of respondents had a formal ER protocol in place and 30% reported plans to introduce one. Ten units (33%) reported that between 20 and 50% of their patients go home the day after elective CS. Three units reported that >50% of patients are national trend towards earlier discharge. However, these data may be subject to selection bias since the units surveyed were actively engaged in clinical trials in reproductive health. The NGT was used to conduct the consensus exercise using an expert panel of health professionals and mothers with experience of elective CS. The NGT is a multistage process designed to combine opinion into group consensus during a structured face-to-face meeting. A systematic review of relevant evidence was completed before the consensus exercise and reviewed in detail at the meeting. The expert panel members were then asked to generate ideas for their preferred components of the ER pathway, all of which were rated twice using a five-point Likert scale. Consensus was defined as 75% agreement (positive or negative). A round-table discussion, led by a QI specialist, was used to test the acceptability of key approaches to implementation and to generate ideas for a QI strategy; this was recorded and transcribed verbatim. Written informed consent was taken from all participants at the start of the workshop. A multi-disciplinary panel of 10 experts (out of 16 invited) attended the consensus workshop, including three patient representatives and seven clinicians (representing anaesthesia, obstetrics, neonatology and midwifery). Consensus was achieved on an ER pathway for elective CS including 15 clinical and five organisational components (Table 1). The expert panel also made recommendations on a preliminary QI strategy to support implementation. This ER pathway has many similarities with existing, published ER pathways for elective CS, although several novel interventions were identified (components


Health Technology Assessment | 2018

A randomised controlled trial and economic evaluation of intraoperative cell salvage during caesarean section in women at risk of haemorrhage: The salvo (cell SALVage in Obstetrics) trial

Khalid S. Khan; Philip Moore; Matthew Wilson; Richard Hooper; Shubha Allard; Ian Wrench; Tracy Roberts; Carol McLoughlin; Lee Beresford; James Geoghegan; Jane P Daniels; Sue Catling; Vicki A. Clark; Paul Ayuk; Stephen C. Robson; Fang Gao-Smith; Matthew Hogg; Louise Jackson; Doris Lanz; Julie Dodds

BACKGROUND Caesarean section is associated with blood loss and maternal morbidity. Excessive blood loss requires transfusion of donor (allogeneic) blood, which is a finite resource. Cell salvage returns blood lost during surgery to the mother. It may avoid the need for donor blood transfusion, but reliable evidence of its effects is lacking. OBJECTIVES To determine if routine use of cell salvage during caesarean section in mothers at risk of haemorrhage reduces the rates of blood transfusion and postpartum maternal morbidity, and is cost-effective, in comparison with standard practice without routine salvage use. DESIGN Individually randomised controlled, multicentre trial with cost-effectiveness analysis. Treatment was not blinded. SETTING A total of 26 UK obstetric units. PARTICIPANTS Out of 3054 women recruited between June 2013 and April 2016, we randomly assigned 3028 women at risk of haemorrhage to cell salvage or routine care. Randomisation was stratified using random permuted blocks of variable sizes. Of these, 1672 had emergency and 1356 had elective caesareans. We excluded women for whom cell salvage or donor blood transfusion was contraindicated. INTERVENTIONS Cell salvage (intervention) versus routine care without salvage (control). In the intervention group, salvage was set up in 95.6% of the women and, of these, 50.8% had salvaged blood returned. In the control group, 3.9% had salvage deployed. MAIN OUTCOME MEASURES Primary - donor blood transfusion. Secondary - units of donor blood transfused, time to mobilisation, length of hospitalisation, mean fall in haemoglobin, fetomaternal haemorrhage (FMH) measured by Kleihauer-Betke test, and maternal fatigue. Analyses were adjusted for stratification factors and other factors that were believed to be prognostic a priori. Cost-effectiveness outcomes - costs of resources and service provision taking the UK NHS perspective. RESULTS We analysed 1498 and 1492 participants in the intervention and control groups, respectively. Overall, the transfusion rate was 2.5% in the intervention group and 3.5% in the control group [adjusted odds ratio (OR) 0.65, 95% confidence interval (CI) 0.42 to 1.01; p = 0.056]. In a planned subgroup analysis, the transfusion rate was 3.0% in the intervention group and 4.6% in the control group among emergency caesareans (adjusted OR 0.58, 95% CI 0.34 to 0.99), whereas it was 1.8% in the intervention group and 2.2% in the control group among elective caesareans (adjusted OR 0.83, 95% CI 0.38 to 1.83) (interaction p = 0.46, suggesting that the difference in effect between subgroups was not statistically significant). Secondary outcomes did not differ between groups, except for FMH, which was higher under salvage in rhesus D (RhD)-negative women with RhD-positive babies (25.6% vs. 10.5%, adjusted OR 5.63, 95% CI 1.43 to 22.14; p = 0.013). No case of amniotic fluid embolism was observed. The additional cost of routine cell salvage during caesarean was estimated, on average, at £8110 per donor blood transfusion avoided. CONCLUSIONS The modest evidence for an effect of routine use of cell salvage during caesarean section on rates of donor blood transfusion was associated with increased FMH, which emphasises the need for adherence to guidance on anti-D prophylaxis. We are unable to comment on long-term antibody sensitisation effects. Based on the findings of this trial, cell salvage is unlikely to be considered cost-effective. FUTURE WORK Research into risk of alloimmunisation among women exposed to cell salvage is needed. TRIAL REGISTRATION Current Controlled Trials ISRCTN66118656. FUNDING This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 2. See the NIHR Journals Library website for further project information.


American Journal of Obstetrics and Gynecology | 2018

Guidelines for Antenatal and Pre-operative care in Cesarean Delivery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations (Part 1)

R. Douglas Wilson; Aaron B. Caughey; Stephen Wood; George A. Macones; Ian Wrench; Jeffrey Huang; Mikael Norman; Karin Pettersson; William Fawcett; Medhat M. Shalabi; Amy Metcalfe; Leah Gramlich; Gregg Nelson

&NA; This Enhanced Recovery After Surgery (ERAS) Guideline for perioperative care in cesarean delivery will provide best practice, evidenced‐based, recommendations for preoperative, intraoperative, and postoperative phases with, primarily, a maternal focus. The focused pathway process for scheduled and unscheduled cesarean delivery for this ERAS Cesarean Delivery Guideline will consider from the time from decision to operate (starting with the 30–60 minutes before skin incision) to hospital discharge. The literature search (1966–2017) used Embase and PubMed to search medical subject headings that included “Cesarean Section,” “Cesarean Section,” “Cesarean Section Delivery” and all pre‐ and intraoperative ERAS items. Study selection allowed titles and abstracts to be screened by individual reviewers to identify potentially relevant articles. Metaanalyses, systematic reviews, randomized controlled studies, nonrandomized controlled studies, reviews, and case series were considered for each individual topic. Quality assessment and data analyses that evaluated the quality of evidence and recommendations were evaluated according to the Grading of Recommendations, Assessment, Development and Evaluation system, as used and described in previous ERAS Guidelines. The ERAS Cesarean Delivery Guideline/Pathway has created a maternal focused pathway (for scheduled and unscheduled surgery starting from 30–60 minutes before skin incision to maternal discharge) with ERAS cesarean delivery consensus recommendations preoperative elements (anesthetic medications, fasting, carbohydrate supplementation, prophylactic antibiotics/skin preparation, ), intraoperative elements (anesthetic management, maternal hypothermia prevention, surgical technique, hysterotomy creation and closure, management of peritoneum, subcutaneous space, and skin closure), perioperative fluid management, and postoperative elements (chewing gum, management of nausea and vomiting, analgesia, timing of food intake, glucose management, antithrombotic prophylaxis, timing of ambulation, urinary management, and timing of maternal and neonate discharge). Limited topics for optimized care and for antenatal education and counselling and the immediate neonatal needs at delivery are discussed. Strong recommendations for element use were given for preoperative (antenatal education and counselling, use of antacids and histamine, H2 receptor antagonists, 2‐hour fasting and small meal within 6 hours surgery, antimicrobial prophylaxis and skin preparation/chlorhexidine‐alcohol), intraoperative (regional anesthesia, prevention of maternal hypothermia [forced warm air, warmed intravenous fluids, room temperature]), perioperative (fluid management for euvolemia and neonatal immediate care needs that include delayed cord clamping), and postoperative (fluid management to prevent nausea and vomiting, antiemetic use, analgesia with nonsteroidal antiinflammatory drugs/paracetamol, regular diet within 2 hours, tight capillary glucose control, pneumatic compression stocking for venous thromboembolism prophylaxis, immediate removal of urinary catheter). Recommendations against the element use were made for preoperative (maternal sedation, bowel preparation), intraoperative (neonatal oral suctioning or increased inspired oxygen), and postoperative (heparin should not be used routinely venous thromboembolism prophylaxis). Because these ERAS cesarean delivery pathway recommendations (elements/processes) are studied, implemented, audited, evaluated, and optimized by the maternity care teams, this will create an opportunity for the focused and optimized areas of care research with further enhanced care and recommendation.


American Journal of Obstetrics and Gynecology | 2018

Guidelines for intraoperative care in Cesarean Delivery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations.

Aaron B. Caughey; Stephen Wood; George A. Macones; Ian Wrench; Jeffrey Huang; Mikael Norman; Karin Pettersson; William Fawcett; Medhat M. Shalabi; Amy Metcalfe; Leah Gramlich; Gregg Nelson; R. Douglas Wilson

&NA; The Enhanced Recovery After Surgery Society guideline for intraoperative care in cesarean delivery will provide best practice, evidenced‐based, recommendations for intraoperative care, with primarily a maternal focus. The “focused” pathway process for scheduled and unscheduled cesarean delivery for this Enhanced Recovery After Surgery cesarean delivery guideline will consider procedure from the decision to operate (starting with the 30–60 minutes before skin incision) through the surgery. The literature search (1966–2017) used Embase and PubMed to search medical subject headings including “cesarean section,” “cesarean section,” “cesarean section delivery,” and all pre‐ and intraoperative Enhanced Recovery After Surgery items. Study selection allowed titles and abstracts to be screened by individual reviewers to identify potentially relevant articles. Metaanalyses, systematic reviews, randomized controlled studies, nonrandomized controlled studies, reviews, and case series were considered for each individual topic. Quality assessment and data analyses evaluated the quality of evidence and recommendations were evaluated according to the Grading of Recommendations, Assessment, Development and Evaluation system as used and described in previous Enhanced Recovery After Surgery Society guidelines. The Enhanced Recovery After Surgery cesarean delivery guideline/pathway has created a maternal focused pathway (for scheduled and unscheduled surgery starting from 30–60 minutes before skin incision to maternal discharge) with Enhanced Recovery After Surgery–directed preoperative elements, intraoperative elements, and postoperative elements. Specifics of the intraoperative care included the use of prophylactic antibiotics before the cesarean delivery, appropriate patient warming intraoperatively, blunt expansion of the transverse uterine hysterotomy, skin closure with subcuticular sutures, and delayed cord clamping. A number of specific elements of intraoperative care of women who undergo cesarean delivery are recommended based on the evidence. The Enhanced Recovery After Surgery Society guideline for intraoperative care in cesarean delivery will provide best practice, evidenced‐based, recommendations for intraoperative care with primarily a maternal focus. When the cesarean delivery pathway (elements/processes) is studied, implemented, audited, evaluated, and optimized by maternity care teams, this will create an opportunity for the focused and optimized areas of care and recommendations to be further enhanced.


BJA: British Journal of Anaesthesia | 1997

Comparison between alfentanil, pethidine and placebo in the treatment of post-anaesthetic shivering.

Ian Wrench; G. Cavill; J. E. H. Ward; A. W. A. Crossley


American Journal of Obstetrics and Gynecology | 2017

LB01: Cell Salvage during Caesarean Section: A Randomised Controlled Trial (The SALVO Trial)

Khalid S. Khan; Philip Moore; Matthew Wilson; Richard Hooper; Shubha Allard; Ian Wrench; Lee Beresford; Tracy E Roberts; Carol McLoughlin; James Geoghegan; Jane P Daniels; Sue Catling; Vicki A. Clark; Paul Ayuk; Stephen C. Robson; Fang Gao-Smith; Matthew Hogg; Doris Lanz; Julie Dodds


BJA: British Journal of Anaesthesia | 2012

Proceedings of the Anaesthetic Research Society MeetingAberdeen Exhibition Centre, Aberdeen, 21–22 June 2012

M. Al Hashimi; Girolamo Calo; Remo Guerrini; J.P. Thompson; David G. Lambert; L. Arblaster; D. Bryden; G. H. Mills; B. P. Atterton; M. D. Wiles; M. E. Walters; J. C. Andrzejowski; A. Bhawnani; S. H. Pennefather; O. Al Rawi; G. N. Russell; J. McShane; R. D. Page; D. Fiszer; N. Fisher; I. M. Carr; G. R. Taylor; P. M. Hopkins; I. Goodhart; J. Andrzejowski; M. Berthoud; G. L. Jones; Ian Wrench; N. Bennett; D. Turnbull

Collaboration


Dive into the Ian Wrench's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Doris Lanz

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Fang Gao-Smith

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Jane P Daniels

University of Birmingham

View shared research outputs
Top Co-Authors

Avatar

Julie Dodds

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Khalid S. Khan

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Lee Beresford

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Ayuk

Royal Victoria Infirmary

View shared research outputs
Researchain Logo
Decentralizing Knowledge